Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1983 Nov;58(11):863–866. doi: 10.1136/adc.58.11.863

Diagnostic delay in cystic fibrosis: lessons from newborn screening.

B Wilcken, S J Towns, C M Mellis
PMCID: PMC1628396  PMID: 6651321

Abstract

Newborn screening for cystic fibrosis (CF) by dried blood spot immunoreactive trypsin (IRT) assay is now feasible, but the benefits are disputed. We have studied the symptoms and signs at diagnosis in 48 babies detected during a newborn screening programme, and also the delay between presentation with symptoms and diagnosis in all 33 babies diagnosed at our CF clinic in the two years before screening began. Eleven of the 48 screened babies had meconium ileus, 16 had gastrointestinal symptoms only, and 14 had both respiratory and gastrointestinal symptoms at the time of diagnosis. Five of the remaining 7 babies developed clear cut symptoms or signs soon after diagnosis. Thus, 96% (46 of 48) of the babies had symptoms by 3 months of age. Of the 33 infants diagnosed clinically in the two years immediately before screening, 13 (39%) were over 12 months of age at diagnosis. Moreover, the mean delay between presentation with symptoms and diagnosis of CF in these infants was 2.6 years. Our data show that the delay between onset of symptoms and diagnosis is far greater than previously supposed and that most babies detected by our screening programme already had symptoms that warranted treatment at the time of their diagnosis.

Full text

PDF
863

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allan J. L., Robbie M., Phelan P. D., Danks D. M. The incidence and presentation of cystic fibrosis in Victoria 1955-1978. Aust Paediatr J. 1980 Dec;16(4):270–273. doi: 10.1111/j.1440-1754.1980.tb01314.x. [DOI] [PubMed] [Google Scholar]
  2. Crossley J. R., Elliott R. B., Smith P. A. Dried-blood spot screening for cystic fibrosis in the newborn. Lancet. 1979 Mar 3;1(8114):472–474. doi: 10.1016/s0140-6736(79)90825-0. [DOI] [PubMed] [Google Scholar]
  3. Dodge J. A., Ryley H. C. Screening for cystic fibrosis. Arch Dis Child. 1982 Oct;57(10):774–780. doi: 10.1136/adc.57.10.774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gitzelmann R. Why we should not screen our newborns for cystic fibrosis. Helv Paediatr Acta. 1981;36(6):493–494. [PubMed] [Google Scholar]
  5. Gottschalk B. Die Mukoviszidose in der Deutschen Demokratischen Republik. Dtsch Gesundheitsw. 1972 Nov 30;27(48):2292–2295. [PubMed] [Google Scholar]
  6. Warwick W. J. Undiagnosed patients with cystic fibrosis. J Chronic Dis. 1980;33(11-12):685–696. doi: 10.1016/0021-9681(80)90055-7. [DOI] [PubMed] [Google Scholar]
  7. Wilcken B., Brown A. R., Urwin R., Brown D. A. Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants. J Pediatr. 1983 Mar;102(3):383–387. doi: 10.1016/s0022-3476(83)80653-2. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES